Why MRNA Stock Is Down After Hours: FDA Rejects Flu Filing
2026-02-11
MRNA stock declined in after-hours trading following the FDA's refusal-to-file letter regarding its mRNA flu vaccine application. Here are the full details, and the key price levels traders are watching.